Completing the Course: Optimizing VTE Prophylaxis Across the Continuum of Care

On-Demand Webcast

Sponsored by North American Center for Continuing Medical Education, LLC

Presenter

Franklin A. Michota, MD
Director of Academic Affairs
Department of Hospital Medicine
Cleveland Clinic Foundation
Cleveland, Ohio

Presenter/Q&A Cohost

Arthur P. Wheeler, MD, FCCP
Associate Professor
Division of Allergy, Pulmonary, and Critical Care Medicine
Vanderbilt University
Director, Medical ICU
Vanderbilt University Medical Center
Nashville, Tennessee

Q&A Cohost

Ann Wittkowsky, PharmD, CACP, FASHP, FCCP
Clinical Professor of Pharmacy
University of Washington
School of Pharmacy
Director of Anticoagulation Services
University of Washington Medical Center
Seattle, Washington

Target Audience

This activity is designed for hospital-based and other physicians and allied healthcare professionals involved in the management of patients at-risk for VTE.

Learning Objectives

After completing this activity, participants should be able to:

• Stratify patients by level of VTE risk in the hospital and post-discharge
• Demonstrate awareness of current evidence, practice guidelines, and quality measures for optimal VTE prophylaxis in the inpatient and outpatient setting
• Implement and/or promote adherence to evidence-based VTE prophylaxis to ensure continuity of prevention from the hospital to post-acute care
• Apply educational tools to advocate for policies and protocols for VTE prevention across at-risk patient populations and practice settings. 

Activity Overview

This on-demand webcast is available with synchronized slides and audio.

To be eligible for documentation of credit, participants must participate in the full activity, complete the 10-question online post-test with a score of 70% or better, and complete the evaluation form. After successful completion of the post-test and evaluation form online at www.naccme.com, participants may immediately print their documentation of credit.

There is no fee associated with this activity.

Participants who have successfully completed the live version of this activity are not eligible to receive credit for this enduring material.

Release Date: October 14, 2009

Expiration Date: October 14, 2010  

Estimated time to complete: 1 hour

This educational activity is a knowledge-based activity.

For questions regarding this educational activity, please contact Angela Scarnici at 609-371-1137.

Hardware/Software Requirements

All educational activities are accessible via a computer with 650 MHz PC, 128 MB RAM, Windows or MAC operating system, Internet Explorer, Netscape, or Safari browsers. Windows Media Player, sound card, and speakers are required for streamed audio. Flash Player, sound card, and speakers are required for video programs. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.

CME Accreditation

North American Center for Continuing Medical Education, LLC (NACCME) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

NACCME designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CPE Accreditation

North American Center for Continuing Medical Education, LLC (NACCME) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity is approved for 1 contact hour (0.1 CEU) of continuing pharmacy education (UAN 276-000-09-027-H01-P).

Any participant wanting to file a grievance with respect to any aspect of a continuing pharmacy education activity accredited by NACCME may contact John Savage, Director, Medical Education, NACCME, in writing at 300 Rike Drive, Suite A, Millstone Township, NJ 08535, or by e-mail at jsavage@naccme.com. The Director of Medical Education will review the grievance and respond within 30 days of receiving the written statement. If the participant is unsatisfied with the response, an appeal to the Vice President, Medical Education, NACCME, may be made for a second level of review.

CNE Accreditation

North American Center for Continuing Medical Education, LLC (NACCME) is an approved provider of continuing nursing education by the Pennsylvania State Nurses Association. Provider #110-3-E-06.

This continuing nursing education activity was approved by the PA State Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

This continuing nursing education activity was approved for 1.0 contact hour(s). 

Provider approved by the California Board of Registered Nursing, Provider #13255 for 1.0 contact hour(s).

Independent Clinical Reviewer: Kenneth A. Bauer, MD, Professor of Medicine, Harvard Medical School, Director, Thrombosis Clinical Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts

Nurse Reviewer: Lynn Oertel, MS, ANP, CACP, Clinical Nurse Specialist, Anticoagulation Management Service, Massachusetts General Hospital, Boston, Massachusetts

Planning Committee

The planning committee comprises Franklin A. Michota, MD, Arthur P. Wheeler, MD, FCCP, Lynn Oertel, MS, ANP, CACP, Ann Wittkowsky, PharmD, CACP, FASHP, FCCP, and Kenneth A. Bauer, MD; Kristin Dickie, Mary Johnson, Randy Robbin, and John Savage, NACCME.

Financial Disclosure and Conflicts of Interest  

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.
                
All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

The faculty has reported the following:
Dr. Bauer: Consultant—Bayer Healthcare, Johnson and Johnson; Promotional speakers bureau—GlaxoSmithKline; Board member—GTC Biotherapeutics Corporation
Dr. Michota: Consultant—Genentech, Osaka, sanofi-aventis U.S.
Ms. Oertel: Consultant—sanofi-aventis U.S.
Dr. Wheeler: Grant/research support—Eli Lilly and Company; Promotional speakers bureau—Boehringer Ingelheim, sanofi-aventis U.S.; Stock shareholder—Cumberland Pharmaceuticals
Wittkowsky: Consultant—Roche Diagnostics; Promotional speakers bureau—sanofi-aventis U.S.
Ms. Dickie, Ms. Johnson, Mr. Robbin, and Mr. Savage have disclosed no relevant financial relationships with any commercial interests.
NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.
The faculty has disclosed that no off-label/unapproved use(s) of drugs and/or devices will be discussed.

Privacy Policy

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

NACCME maintains physical, electronic and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2009 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education.

Grant Support

Supported by an educational grant from sanofi-aventis U.S.